Current bulk and single-cell technologies to detect and isolate CD138+ MM CTCs include flow cytometry (FC) [17,21], the combined CellSearch-DEPArray method (Silicon Biosystems) [22,23], and custom microfluidics [24]. Here, SDC1 is linked to Miyoshi myopathy.